Global Intravenous Solutions Market Growth 2025-2031

Publication ID:

LPI07254734

Publication Date:

July 4, 2025

Pages:

Publisher:

LPI

Countries:

Global [1]

USD 3,660.00

Pharmaceutical Manufacturing [2]

Healthcare [3]

Pharma & Healthcare [4]

Description:

The global Intravenous Solutions market size is predicted to grow from US$ 12840 million in 2025 to US$ 18770 million in 2031; it is expected to grow at a CAGR of 6.5% from 2025 to 2031.
Intravenous Solutions is the infusion of liquid substances directly into a vein. Therapies administered intravenously are often included in the designation of specialty drugs. Intravenous infusions are commonly referred to as drips because many systems of administration employ a drip chamber, which prevents air from entering the blood stream (air embolism), and allows an estimation of flow rate.
Global Intravenous Solutions key players include Baxter, Kelun Group, Fresenius Kabi, etc. Global top three manufacturers hold a share over 35%.
Asia-Pacific is the largest market, with a share over 45%, followed by Europe, and North America, both have a share over 40 percent.
In terms of product, Crystalloids is the largest segment, with a share over 75%. And in terms of application, the largest application is Basic IV Solutions, followed by Nutrient Infusion Solution, etc.
The 鈥淚ntravenous Solutions Industry Forecast鈥� looks at past sales and reviews total world Intravenous Solutions sales in 2024, providing a comprehensive analysis by region and market sector of projected Intravenous Solutions sales for 2025 through 2031. With Intravenous Solutions sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Intravenous Solutions industry.
This Insight Report provides a comprehensive analysis of the global Intravenous Solutions landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Intravenous Solutions portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms鈥� unique position in an accelerating global Intravenous Solutions market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Intravenous Solutions and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Intravenous Solutions.
This report presents a comprehensive overview, market shares, and growth opportunities of Intravenous Solutions market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
Crystalloids
Colloids
Others
Segmentation by Application:
Basic IV Solutions
Nutrient Infusion Solution
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
Baxter
Kelun Group
Fresenius Kabi
Otsuka
ICU Medical
Fresenius Kabi
JW Life Science
B. Braun Melsungen
Key Questions Addressed in this Report
What is the 10-year outlook for the global Intravenous Solutions market?
What factors are driving Intravenous Solutions market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Intravenous Solutions market opportunities vary by end market size?
How does Intravenous Solutions break out by Type, by Application?

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Intravenous Solutions Annual Sales 2020-2031
2.1.2 World Current & Future Analysis for Intravenous Solutions by Geographic Region, 2020, 2024 & 2031
2.1.3 World Current & Future Analysis for Intravenous Solutions by Country/Region, 2020, 2024 & 2031
2.2 Intravenous Solutions Segment by Type
2.2.1 Crystalloids
2.2.2 Colloids
2.2.3 Others
2.3 Intravenous Solutions Sales by Type
2.3.1 Global Intravenous Solutions Sales Market Share by Type (2020-2025)
2.3.2 Global Intravenous Solutions Revenue and Market Share by Type (2020-2025)
2.3.3 Global Intravenous Solutions Sale Price by Type (2020-2025)
2.4 Intravenous Solutions Segment by Application
2.4.1 Basic IV Solutions
2.4.2 Nutrient Infusion Solution
2.4.3 Others
2.5 Intravenous Solutions Sales by Application
2.5.1 Global Intravenous Solutions Sale Market Share by Application (2020-2025)
2.5.2 Global Intravenous Solutions Revenue and Market Share by Application (2020-2025)
2.5.3 Global Intravenous Solutions Sale Price by Application (2020-2025)
3 Global by Company
3.1 Global Intravenous Solutions Breakdown Data by Company
3.1.1 Global Intravenous Solutions Annual Sales by Company (2020-2025)
3.1.2 Global Intravenous Solutions Sales Market Share by Company (2020-2025)
3.2 Global Intravenous Solutions Annual Revenue by Company (2020-2025)
3.2.1 Global Intravenous Solutions Revenue by Company (2020-2025)
3.2.2 Global Intravenous Solutions Revenue Market Share by Company (2020-2025)
3.3 Global Intravenous Solutions Sale Price by Company
3.4 Key Manufacturers Intravenous Solutions Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Intravenous Solutions Product Location Distribution
3.4.2 Players Intravenous Solutions Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 World Historic Review for Intravenous Solutions by Geographic Region
4.1 World Historic Intravenous Solutions Market Size by Geographic Region (2020-2025)
4.1.1 Global Intravenous Solutions Annual Sales by Geographic Region (2020-2025)
4.1.2 Global Intravenous Solutions Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Intravenous Solutions Market Size by Country/Region (2020-2025)
4.2.1 Global Intravenous Solutions Annual Sales by Country/Region (2020-2025)
4.2.2 Global Intravenous Solutions Annual Revenue by Country/Region (2020-2025)
4.3 Americas Intravenous Solutions Sales Growth
4.4 APAC Intravenous Solutions Sales Growth
4.5 Europe Intravenous Solutions Sales Growth
4.6 Middle East & Africa Intravenous Solutions Sales Growth
5 Americas
5.1 Americas Intravenous Solutions Sales by Country
5.1.1 Americas Intravenous Solutions Sales by Country (2020-2025)
5.1.2 Americas Intravenous Solutions Revenue by Country (2020-2025)
5.2 Americas Intravenous Solutions Sales by Type (2020-2025)
5.3 Americas Intravenous Solutions Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Intravenous Solutions Sales by Region
6.1.1 APAC Intravenous Solutions Sales by Region (2020-2025)
6.1.2 APAC Intravenous Solutions Revenue by Region (2020-2025)
6.2 APAC Intravenous Solutions Sales by Type (2020-2025)
6.3 APAC Intravenous Solutions Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Intravenous Solutions by Country
7.1.1 Europe Intravenous Solutions Sales by Country (2020-2025)
7.1.2 Europe Intravenous Solutions Revenue by Country (2020-2025)
7.2 Europe Intravenous Solutions Sales by Type (2020-2025)
7.3 Europe Intravenous Solutions Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Intravenous Solutions by Country
8.1.1 Middle East & Africa Intravenous Solutions Sales by Country (2020-2025)
8.1.2 Middle East & Africa Intravenous Solutions Revenue by Country (2020-2025)
8.2 Middle East & Africa Intravenous Solutions Sales by Type (2020-2025)
8.3 Middle East & Africa Intravenous Solutions Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Intravenous Solutions
10.3 Manufacturing Process Analysis of Intravenous Solutions
10.4 Industry Chain Structure of Intravenous Solutions
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Intravenous Solutions Distributors
11.3 Intravenous Solutions Customer
12 World Forecast Review for Intravenous Solutions by Geographic Region
12.1 Global Intravenous Solutions Market Size Forecast by Region
12.1.1 Global Intravenous Solutions Forecast by Region (2026-2031)
12.1.2 Global Intravenous Solutions Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Intravenous Solutions Forecast by Type (2026-2031)
12.7 Global Intravenous Solutions Forecast by Application (2026-2031)
13 Key Players Analysis
13.1 Baxter
13.1.1 Baxter Company Information
13.1.2 Baxter Intravenous Solutions Product Portfolios and Specifications
13.1.3 Baxter Intravenous Solutions Sales, Revenue, Price and Gross Margin (2020-2025)
13.1.4 Baxter Main Business Overview
13.1.5 Baxter Latest Developments
13.2 Kelun Group
13.2.1 Kelun Group Company Information
13.2.2 Kelun Group Intravenous Solutions Product Portfolios and Specifications
13.2.3 Kelun Group Intravenous Solutions Sales, Revenue, Price and Gross Margin (2020-2025)
13.2.4 Kelun Group Main Business Overview
13.2.5 Kelun Group Latest Developments
13.3 Fresenius Kabi
13.3.1 Fresenius Kabi Company Information
13.3.2 Fresenius Kabi Intravenous Solutions Product Portfolios and Specifications
13.3.3 Fresenius Kabi Intravenous Solutions Sales, Revenue, Price and Gross Margin (2020-2025)
13.3.4 Fresenius Kabi Main Business Overview
13.3.5 Fresenius Kabi Latest Developments
13.4 Otsuka
13.4.1 Otsuka Company Information
13.4.2 Otsuka Intravenous Solutions Product Portfolios and Specifications
13.4.3 Otsuka Intravenous Solutions Sales, Revenue, Price and Gross Margin (2020-2025)
13.4.4 Otsuka Main Business Overview
13.4.5 Otsuka Latest Developments
13.5 ICU Medical
13.5.1 ICU Medical Company Information
13.5.2 ICU Medical Intravenous Solutions Product Portfolios and Specifications
13.5.3 ICU Medical Intravenous Solutions Sales, Revenue, Price and Gross Margin (2020-2025)
13.5.4 ICU Medical Main Business Overview
13.5.5 ICU Medical Latest Developments
13.6 Fresenius Kabi
13.6.1 Fresenius Kabi Company Information
13.6.2 Fresenius Kabi Intravenous Solutions Product Portfolios and Specifications
13.6.3 Fresenius Kabi Intravenous Solutions Sales, Revenue, Price and Gross Margin (2020-2025)
13.6.4 Fresenius Kabi Main Business Overview
13.6.5 Fresenius Kabi Latest Developments
13.7 JW Life Science
13.7.1 JW Life Science Company Information
13.7.2 JW Life Science Intravenous Solutions Product Portfolios and Specifications
13.7.3 JW Life Science Intravenous Solutions Sales, Revenue, Price and Gross Margin (2020-2025)
13.7.4 JW Life Science Main Business Overview
13.7.5 JW Life Science Latest Developments
13.8 B. Braun Melsungen
13.8.1 B. Braun Melsungen Company Information
13.8.2 B. Braun Melsungen Intravenous Solutions Product Portfolios and Specifications
13.8.3 B. Braun Melsungen Intravenous Solutions Sales, Revenue, Price and Gross Margin (2020-2025)
13.8.4 B. Braun Melsungen Main Business Overview
13.8.5 B. Braun Melsungen Latest Developments
14 Research Findings and Conclusion

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂